LIVANOVA - HEART VALVE BUSINESS
The LivaNova HV business is a global player in surgical heart valves with world-class products and compelling growth opportunities.
LIVANOVA - HEART VALVE BUSINESS
Industry:
Health Care Medical
Address:
London, England, United Kingdom
Country:
United Kingdom
Status:
Active
Similar Organizations
Physicool
Physicool is used globally in hospitals, therapy practices, out on the sports field and at home
More informations about "LivaNova - Heart Valve Business"
LivaNova Completes Initial Closing of Heart Valve Business to …
Jun 1, 2021 Additional local business closings to occur later this year. LONDON--(BUSINESS WIRE)--Jun. 1, 2021-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology …See details»
LivaNova - Heart Valve Business - Crunchbase Company Profile
9,927 Number of Organizations • $80.9B Total Funding Amount • 9,158 Number of Investors. Track . Closed Europe Health Care Companies . ... LivaNova - Heart Valve Business acquired …See details»
LivaNova and Gyrus Capital Enter into Agreement for the Purchase …
“The LivaNova HV business is a global player in surgical heart valves with world-class product s and compelling growth opportunities ,” said Guy Semmens, Managing Partner at Gyrus …See details»
LivaNova to exit heart valve business via €60M carve …
In its most recent earnings report, LivaNova’s heart valve business brought in $21.1 million across the third quarter—down about 27% compared to the same quarter last year, with declines ...See details»
LivaNova Completes Initial Close of Heart Valve Biz …
Jun 1, 2021 LivaNova said it expected the heart valve business to generate net revenues of about $70 million during the period of June 1 through Dec. 31, 2021. “The completion of the heart valve sale to Gyrus Capital allows LivaNova to …See details»
LivaNova Divests Heart Valve Business to Gyrus Capital …
Dec 3, 2020 At one point, LivaNova built up its presence in heart valves with the acquisition of Maple Grove, MN-based Caisson International in 2017 for $72 million. LivaNova had previously been an investor in the mitral valve specialist. …See details»
LivaNova completes initial divestiture of its heart valve business
Jun 2, 2021 LivaNova has successfully completed the initial closing of the divestiture of its heart valve business to Gyrus Capital, an investment firm dedicated to investments in the healthcare …See details»
Gyrus Capital and Livanova enter into agreement to …
London, December 3rd, 2020 – Gyrus Capital is pleased to announce that it has reached an agreement with LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, to acquire the LivaNova’s Heart …See details»
LivaNova and Gyrus Capital Enter into Agreement for the Purchase …
Dec 3, 2020 LONDON--(BUSINESS WIRE)--Dec. 3, 2020-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Gyrus Capital (Gyrus), an …See details»
LivaNova to Restructure its Heart Valve Business Line and End …
Nov 20, 2019 The LivaNova heart valve business line represented nearly $130 million in revenue for full-year 2018 and has experienced a revenue decline over the last five years …See details»
LivaNova and Gyrus Capital Enter into Agreement for the
Dec 3, 2020 “The LivaNova HV business is a global player in surgical heart valves with world-class products and compelling growth opportunities,” said Guy Semmens, Managing Partner …See details»
LivaNova offloads heart valve tech to Gyrus Capital following …
Dec 3, 2020 LivaNova's heart valves business — which includes sutureless tissue valves, mechanical valves, traditional tissue valves and annuloplasty rings — accounted for 18% of …See details»
LivaNova moves forward with heart valve business sale
Jun 1, 2021 London-based LivaNova’s former heart valve business includes the Perceval sutureless aortic valve and the Memo 4D semi-rigid mitral annuloplasty ring. The company …See details»
LivaNova Completes Initial Closing of Heart Valve Business to
Jun 1, 2021 LivaNova PLC, a market-leading medical technology and innovation company, today announced it has successfully completed the initial closing of the divestiture of its heart …See details»
LivaNova reaches agreement to sell its heart valve business
Dec 3, 2020 LivaNova has entered into an agreement with investment firm Gyrus Captial whereby entities funded and controlled by Gyrus will acquire the LivaNova heart valve (HV) …See details»
LivaNova PLC sells its heart valve business to Gyrus Capital and …
Dec 5, 2020 LivaNova PLC and Gyrus Capital (Gyrus), an investment firm dedicated to investments in the healthcare and sustainability sectors, announced they have entered into an …See details»
LivaNova Sells Heart Valve Business to Gyrus Capital - DAIC
Jun 2, 2021 LivaNova expected the heart valve business to generate net revenues of approximately $70 million during the period of June 1 through Dec. 31, 2021. After excluding …See details»
LivaNova and Gyrus Capital Enter into Agreement for the Purchase …
London, December 3, 2020 – LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Gyrus Capital (Gyrus), an investment firm dedicated …See details»
Livanova (Heart Valve Business) - PitchBook
Livanova (Heart Valve Business) General Information Description. Provider of surgical heart valves and other therapeutic devices based in London, United Kingdom. The company's …See details»
LivaNova Ends Caisson TMVR Program, Will Restructure Its Heart …
Nov 19, 2019 According to the company, the LivaNova heart valve business line represented nearly $130 million in revenue for full-year 2018 and has experienced a revenue decline over …See details»